However, looking in detail at the three time intervals ( Figure 3B ), an increasing trend in the use of both agents to support the clinical analysis comes out.
← all excerpts
Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review.
1
—
—